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may be a locus on chromosome 10 that leads to reduced renalLinkage of creatinine clearance to chromosome 10 in Utah pedi-
function that can be detected while subjects are still healthy.grees replicates a locus for end-stage renal disease in humans
Identification of the responsible gene may help in predictingand renal failure in the fawn-hooded rat.
renal disease progression in susceptible patients.Background. Renal failure is an important health concern
for persons with hypertension and diabetes. In the fawn-
hooded rat, a renal failure locus, Rf-1, has been identified on rat
chromosome 1. A study of African American sibpairs with Kidney disease and declining renal function leadingend-stage renal disease (ESRD) replicated this finding on the
to end-stage renal disease (ESRD) are important healthorthologous region in humans, chromosome 10, with a maxi-
problems and are extremely costly to manage. Althoughmum logarithm of odds (LOD) score of 3.4. An important
question is whether this region can be detected in healthy risk factors such as hypertension and diabetes may be
subjects prior to onset of ESRD by examining creatinine clear- associated with or accelerate a decline in renal function,
ance as an indicator of early renal damage. other factors are clearly involved. In addition, it appearsMethods. We analyzed 49 Utah Caucasian pedigrees and
that there is a strong familial aggregation of ESRD thatperformed quantitative nonparametric linkage analysis using
is independent of hypertension and diabetes [1]. In in-21 markers spanning chromosome 10. Pedigree members (mean
age of 40  17) were examined up to three different times vestigating the genetic causes of renal failure in rat mod-
over 10 years, with creatinine clearance measured at each exam. els of the disease, two important regions of the genome
For examination 1, three overnight, timed, 12-hour urine sam- have been linked to this trait in the fawn-hooded rat [2].ples were obtained and averaged. One 12-hour sample was
The strongest of these regions is on rat chromosome 1obtained for examinations 2 and 3.
and was named Rf-1. The maximum logarithm of oddsResults. Heritabilities of creatinine clearance were 0.33 (N
1360), 0.36 (N  1196), and 0.53 (N  718) for the three (LOD) scores for linkage to phenotypes related to renal
examinations, respectively. The nonparametric LOD score for failure were 3.7 for plasma creatinine, 8.9 for urinary
examination 1 was 1.4 at marker D10S677 (117 cM). The protein, and 8.4 for the macroscopic renal index scoreLOD score at examination 2, an average of 21⁄2 years later, [2]. The orthologous region in humans lies on humanwas 1.8 at marker D10S1239 (123 cM) and 1.9 at marker
chromosome 10. A study of first-degree relatives in Afri-D10S1425 (137 cM). The LOD score at examination 3, an
average of 10 years from baseline, was 2.1 at marker D10S2470 can American families with ESRD showed that elevated
(113 cM). Thus, there is consistent evidence of linkage to serum creatinine, proteinuria, or ESRD was present in
this region from three different examinations spanning a period 70% of the families [3]. Therefore, the renal failure phe-of 10 years.
notypes linked in the rat also show strong familial aggre-Conclusions. These linkage results confirm the ESRD link-
gation in humans. A previous linkage analysis of 129age and the rat renal failure linkage to this region even though
the LOD score is somewhat weaker, probably due to the less African American sibpairs with ESRD did not find sig-
severe phenotype that was analyzed. It also suggests that there nificant linkage to this region [4]. However, an abstract
using a greatly expanded sample of these sibpairs (N 
356) recently reported significant linkage, with a maxi-Key words: creatinine clearance, linkage analysis, pedigrees, renal dis-
ease. mum LOD score of 3.4 (Freedman BI et al, J Am Soc
Nephrol 12:71A, 2001). The full results of this abstractReceived for publication February 4, 2002
are reported elsewhere [5].and in revised form April 15, 2002
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also pre-clinical manifestations of ESRD, namely, renal sured serum and urine creatinine on a Roche Fara
function as measured by creatinine clearance measure- autoanalyzer and no machine comparisons were done at
ments. If the genetic mechanism of this unknown gene the time (1991). Therefore, the creatinine clearance at
leads to slowly deteriorating renal function, creatinine examination 3 should not be directly compared to exami-
clearance should be compromised long before the clinical nations 1 and 2, but within examination measurements
diagnosis of ESRD is made. Therefore, the genetic effects are consistent for all subjects. Longitudinal changes in
of this gene may be able to be observed early in the patho- creatinine clearance were calculated as simple differ-
physiological disease processes and could be a marker ences of examination 3 minus examination 1 or examina-
of those persons at high risk of developing ESRD. tion 2 minus examination 1 measurements.
This study reports on linkage of creatinine clearance Creatinine clearance measurements and differences
measurements obtained from three different clinical ex- between examinations were adjusted for gender, base-
aminations over 10 years in large Utah pedigrees to the line age, age2, age3 and body mass index (BMI) by multi-
previously reported region on chromosome 10. Pedigree ple regression analysis. The unadjusted mean was added
members were healthy adults because diabetics and per- to the residuals. Excluded from analysis in this study were
sons with diagnosed kidney disease were excluded from all subjects under the age of 18 at examination 1 and
analysis. persons with diabetes (N  21) at examination 1. Only
three subjects became diabetic between examinations 1
and 2 and three more between examinations 2 and 3 andMETHODS
these persons were retained in the analysis. Persons with
Beginning in 1980, 2500 members of 98 Utah pedigrees a baseline history of recurrent urinary tract infections
were examined at the Cardiovascular Genetics Clinic of or any form of diagnosed kidney disease were also ex-
the University of Utah. Most pedigrees were ascertained cluded (N  79). Two subjects with very high creatinine
for two or more early coronary heart disease deaths or
clearance were excluded because they appeared to be
two or more stroke deaths in the sibship of the founding
outliers in the distribution. No adjustment was made for
generation of the pedigree. A few pedigrees were ascer-
hypertension, which was present in 7%, 9%, and 14%tained for the presence of hypertension in a proband [6].
of subjects at examinations 1 to 3, respectively.In 1983, over 90% of these persons were re-examined
The Mammalian Genotyping Service [9] providedin our clinic. Another examination of a subset of these
714,335 marker genotypes on 421 markers, 1855 individ-subjects began in 1990 for a 10-year follow-up of disease
uals, and 49 pedigrees after data cleaning. Twenty-oneend points and changes in clinically measured variables.
markers were analyzed on chromosome 10. Details ofSince the major goal of this 10-year follow-up was to
the markers and genetic map can be obtained from theobtain hypertension incidence data, older family mem-
Mammalian Genotyping Service website (http://research.bers were targeted for clinical examination, although the
marshfieldclinic.org/genetics). Pedigree relationships werevital status of 99% of the original cohort was updated.
assessed by the ASPEX program (f tp://lahmed.stanford.Almost 33% of the original cohort of 2500 family mem-
edu/pub/aspex/index.html) and a modified version of PAPbers were under the age 18 at the first examination and
[10] and marker compatibilities were checked by PED-were only recruited for the third examination if they
CHECK [11]. There were 1360 persons with both markerlived close to the clinic. Only 60% of examination 1
and creatinine clearance data from examination 1, 1196subjects were examined at the third examination. De-
from examination 2, and 718 from examination 3. Multi-scriptions of additional variables measured and charac-
point haplotypes were estimated by the Markov chainteristics of the ascertained pedigrees may be found in
Monte Carlo methods of Go¨ring and Terwilliger [12] andother references [6–8].
Thomas et al [13] to help differentiate identity-by-descentSerum creatinine was measured in the morning after
from identity-by-state sharing at each marker. A nonpara-an overnight fast at the clinical laboratory of the Univer-
metric statistic of linkage was calculated at each markersity of Utah hospital. At examination 1, timed, 12-hour,
using these haplotypes following the method of Kruglyakovernight urine samples were collected from three differ-
et al [14], but extended for quantitative traits by Campent days. Two samples were collected from weekdays
et al [15] using the following formula for each pedigreeand one sample from the weekend. Urine volume and
and marker position:creatinine were measured from each sample, with the
resulting measurements averaged and converted to h (i(h) (qh-q0))2amount of creatinine per 24 hours. Creatinine clearance
The mean creatinine clearance of the pedigrees usedwas measured as the ratio of 24-hour urine to serum
for q0, qi is the quantitative trait value, the first sum iscreatinine amounts. Examinations 2 and 3 collected only
taken over all haplotypes (h) in the pedigree, and thea single 12-hour overnight sample. Laboratory autoana-
second sum is taken over individuals (i) carrying haplo-lyzers changed between examinations 2 and 3. At exami-
nation 3 the Cardiovascular Genetics Laboratory mea- type (h).
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Table 2. Heritabilities ( SE) of creatinine clearance and changesTable 1. Characteristics (mean  SD) of the subjects used for the
linkage analysis of creatinine clearance in creatinine clearance for the three examinations
Examination HeritabilityMales Females
Variablea (N  672) (N  688)
1 0.330.05
2 0.360.06Age years 39.916.3 40.116.9
Body mass index kg/m2 23.65.0 23.36.4 3 0.530.07
Change from examination 1 to 2 0.200.06Current smoker % 31 15
Systolic blood pressure mm Hg 11111 10411 Change from examination 1 to 3 0.400.07
Diastolic blood pressure mm Hg 6310 629
Total cholesterol mg/dL 19042 19140
Triglycerides mg/dL 10763 9748
High-density lipoprotein cholesterol mg/dL 4511 5212
Serum creatinine mg/dL (exam 1) 1.000.15 0.820.13 were 0.32, 0.27 and 0.56 for examinations 1, 2, and 3,
Serum creatinine mg/dL (exam 2) 1.020.15 0.850.14
respectively.Serum creatinine mg/dL (exam 3) 1.050.15 0.840.13
Creatinine clearance mL/min (exam 1) 13241 13036 Figure 1 shows the linkage plots for creatinine clear-
Creatinine clearance mL/min (exam 2) 12353 12145 ance for each of the three examinations. Examination 3
Creatinine clearance mL/min (exam 3) 13677 14164
shows the best signal for linkage (2.09) at marker D10-
a Sample sizes of 1360 for examination 1, 1196 for examination 2, and 718 for S2470 located at 113 cM on the Marshfield map. Exami-examination 3. Blood pressure, lipid, and creatinine variables adjusted by multi-
ple regression for gender, age, age2, age3, and body mass index nation 2 showed two peaks further downstream (1.82
and 1.94) but clearly overlapping the examination 1 sig-
nal. The maximum examination 1 nonparametric LOD
score (1.42) occurred at marker D10S677 at 117 cM, the
RESULTS marker next to the examination 3 peak.
Table 1 shows the clinical characteristics of the sample Figure 2 shows the nonparametric LOD score plots for
at examination 1. Serum creatinine increased slightly the change in creatinine clearance. The nonparametric
over the three examination periods. As mentioned above, LOD scores (1.68 at 143 cM and 1.05 at 101 cM) were
direct comparisons of urine creatinine cannot be made lower than for the cross-sectional analysis of creatinine
between examinations 1 or 2 and examination 3 because clearance. The curves seem to follow the pattern and
of laboratory assay changes over the 10-year period. The location dictated by the follow-up examination results
gender distribution at examination 1 was 51% female and rather than the baseline results.
49% male. All subjects were Caucasian. There were only
three males with a serum creatinine greater than 1.6 mg/dL
DISCUSSION[one at examination 2 (1.9 mg/dL) and two at examina-
This study analyzed multiple creatinine clearance mea-tion 3 (1.7 and 2.2 mg/dL)]. Only one female had a serum
surements from a collection of healthy, Caucasian pedi-creatinine greater than 1.4 mg/dL (1.7 mg/dL at examina-
gree members. Significant heritability estimates were ob-tion 3). Gender, a cubic polynomial in age, and BMI
explained 43%, 24%, and 9% of the creatinine clearance tained for creatinine clearance measurements obtained at
each of three clinical examinations and also for changesvariance at examinations 1, 2, and 3, respectively.
Comparisons of creatinine clearance among individu- in creatinine clearance between examinations. The ge-
netic underpinnings of creatinine clearance appear to beals from each of the three methods of pedigree ascertain-
ment showed that the coronary heart disease- and hyper- as strong or stronger for cross-sectional measurements
within pedigrees as for longitudinal changes in these mea-tension-ascertained pedigrees had significantly lower
baseline means ( SE) than stroke-ascertained pedigree sures. While increased measurement error obtained us-
ing the difference of two measurements and daily phys-members (128  1.5, 132  2.0, and 139  2.2 mL/min,
respectively). There were no differences among pedigree iological variation could have reduced the heritability
estimates of the changes, it appears that there is no clearascertainment methods for longitudinal changes in creat-
inine clearance. advantage in studying the creatinine clearance changes
to detect underlying associated genes compared to aTable 2 shows the significant heritability estimates of
creatinine clearance for each of the three examinations, single examination measurement.
The important result of this study was that significantas well as for the changes between examinations. The
heritability estimates for the longitudinal changes were (P  0.05) LOD scores were obtained from a linkage
analysis of creatinine clearance to markers on chromo-significant despite the correlations of creatinine clear-
ance between examinations 1 and 2 and examinations 1 some 10 at each of three examinations over a 10-year
period. These results replicate previous findings from theand 3 being only 0.20 and 0.18, respectively. If herita-
bilities are calculated using only subjects who had all rat [2] and from African American sibpairs with ESRD
[5]. The LOD score of 3.4 from the ESRD sample wasthree examinations so that the heritabilities among ex-
aminations were more directly comparable, the estimates much higher than that found in this study, probably for
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Fig. 1. Nonparametric logarithm of odds (NPL
LOD) score plots of chromosome 10 markers
and creatinine clearance measurements from
each of the three clinical examinations. Sym-
bols are: (), examination 1; (), examination
2; (), examination 3.
Fig. 2. Nonparametric logarithm of odds (NPL
LOD) score plots of chromosome 10 markers and
changes in creatinine clearance measurements be-
tween examinations 1 and 2 () and between exam-
inations 1 and 3 ().
multiple reasons. African Americans have a much higher specifically for hypertension may have diluted a linkage
signal for creatinine clearance. For Caucasian hyperten-risk of renal failure and ESRD than Caucasians. Using
a severe disease end point for analysis, such as ESRD, sive sibpairs in the HyperGEN study, the LOD score
for creatinine clearance was 1.4 at 135 cM (unpublishedshould increase the accuracy of classification. It may also
make the sample more homogeneous. Analyzing a risk results from [16]), despite the selection for hypertension.
Even though subjects from the hypertension-ascertainedfactor for development of ESRD, as was done in the
current study, may include many subjects who have de- pedigrees in the current study had lower creatinine clear-
ance measurements than those for stroke pedigrees, ex-creased renal function but who may never develop ESRD.
A genome search of creatinine clearance in the Hyper- amination of the individual pedigree LOD scores sug-
gests that most of the linkage signal was derived fromGEN study of hypertension [16] did not find suggestive
linkage on chromosome 10 for African American hyper- the coronary heart disease-ascertained pedigrees that had
the lowest mean creatinine clearance. Therefore, thesetensive siblings (unpublished results). The linkage find-
ings in the rat for Rf-1 indicated that this locus was not observations suggest that hypertension and stroke may
not be closely associated with the underlying gene re-linked to blood pressure. Therefore, selection of sibpairs
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sponsible for the linkage signal. LOD scores in the range clearance measurements are somewhat larger than seen
in other studies. Since creatinine is fairly stable andof 1.4 to 2.1, as found for analyses of creatinine clearance,
are more difficult to replicate in every sample tested than straightforward to measure, as is urine volume, the most
likely sources of error introduced would be from misre-are LOD scores above 3 and more firm conclusions about
the association of hypertension or coronary heart disease porting of collection times or incomplete sample collec-
tion, increasing the variance of the measurements. Ifwith this locus and linkage signal differences between
Caucasians and African Americans must await further this type of error were random, it would probably not
introduce spurious linkage signals. One would not expectdata.
Given the above considerations, it may be remarkable segregation of errors in nuclear families. The observation
that linkage was found using three different clinical ex-that linkage to the same chromosomal region could be
found analyzing creatinine clearance in healthy subjects. aminations and two different assays for urine creatinine
reduces the likelihood of spurious linkage. The mostIf the linkage results from this sample and the ESRD
sample represent the same gene predisposing to ESRD, likely reason for the larger standard deviations is the
identification of this gene may help predict those who selected population of large pedigrees used in this study.
are at increased risk of ESRD. Because of the mild LOD scores detected in this study,
There are a number of caveats that apply to the find- identification of the underlying gene would appear to be
ings of this study. The lowest LOD score occurred for difficult. The peak LOD scores for examinations 1 and
examination 1, which theoretically may have been ex- 3 were slightly upstream from the putative location of
pected to give the highest LOD score because the aver- Rf1, with the examination 2 LOD score closer to the
age of three different 12-hour urine collections was used presumed location and coinciding more with the Hyper-
to calculate creatinine clearance. However, the heritabil- GEN finding [16]. Therefore, it is not clear if the underly-
ity estimate of creatinine clearance was highest for exam- ing gene linked to creatinine clearance is the same as
ination 3, thereby providing a greater chance for a ge- the Rf1 gene. Only a few of the pedigrees in the sample
netic locus to explain a greater proportion of the trait appeared to be responsible for the linkage results and
variation, resulting in a higher LOD score. We also spec- would need to be supplemented with a much larger set
ulate that the LOD scores increased over examinations of linked pedigrees in order to refine the region. Fortu-
1 to 3 because of the aging of the pedigree members. nately, the linkage of renal failure phenotypes in the rat
Even though children under age 18 at examination 1 to this region would allow the location of the rat gene
were excluded from all analyses, persons at examination to be refined and perhaps identified. The results from
3 were 10 years older than they were at examination 1. the African American sample would also be more ame-
Creatinine clearance normally decreases somewhat with nable for localization of the responsible gene. This gene
age, but if there is a differential effect on that decline by may then be tested in these pedigrees to verify that it is
genotype, this difference may be more easily detectable the gene responsible for the linkage.
during middle age than during young adulthood. The
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